论文信息 - Imatinib Is Safe and Effective In Patients with Refractory Chronic Graft Versus Host Disease: Analysis of Two Consecutive Prospective GITMO* Studies.*Gruppo Italiano Trapianto Midollo Osseo - 字舞流文

Imatinib Is Safe and Effective In Patients with Refractory Chronic Graft Versus Host Disease: Analysis of Two Consecutive Prospective GITMO* Studies.*Gruppo Italiano Trapianto Midollo Osseo

G. Lucchini | A. Bosi | F. Locatelli | M. Zecca | F. Patriarca | P. Corradini | C. Selleri | P. Leoni | P. Iacopino | M. Badiali | A. Olivieri | A. Bacigalupo | G. Gini | M. Cimminiello | N. Mordini | A. Donelli